Department of Geriatric Medicine, Aalborg University Hospital
Aalborg, Northen Jutland, 9000, Denmark
NCT Number: NCT04572139
The purpose of this study to age-related differences to the response of a combined pituitary stimulation test with TRH, LHRH and ACTH.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Aalborg, Northen Jutland, 9000, Denmark
Participants will be recruited in three different age intervals: 18-45 years, 55-80 years and 80+ years. These participants will all undergo the same stimulation test with 0.1 mg LHRH, 0.2 mg TRH, and 0.25 mg ACTH (Synachten). The tests will be perfomed at the same time of day for all particpants (between 08:15 and 08:45) and participants will be fasting for the test. Blood samples will be taken just before and at 10, 20, 30, 45, 60, 90 and 120 minutes following the stimulation test. Serum from blood samples will be stored at -20 degrees until analysis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pituitary stimulation with 0.1 mg LHRH, 0.2 mg TRH and 0.25 mg ACTH
Time frame: Immediately after procedure.
Differences will be measured by calculating the area under the curve adjusted for the basal level for the time of the test period.
Time frame: Immediately after procedure.
Differences will be measured by calculating the area under the curve adjusted for the basal level for the time of the test period.
Time frame: Immediately after procedure.
Differences will be measured by calculating the area under the curve adjusted for the basal level for the time of the test period.
Time frame: Immediately after procedure.
Differences will be measured by calculating the area under the curve adjusted for the basal level for the time of the test period.
Time frame: Immediately after procedure.
Differences will be measured by calculating the area under the curve adjusted for the basal level for the time of the test period.
Time frame: Immediately after procedure.
Both absolute peak values and peak values relative to basal level will be calculated.
Time frame: Immediately after procedure.
Both absolute peak values and peak values relative to basal level will be calculated.
Time frame: Immediately after procedure.
Both absolute peak values and peak values relative to basal level will be calculated.
Time frame: Immediately after procedure.
Both absolute peak values and peak values relative to basal level will be calculated.
Time frame: Immediately after procedure.
Both absolute peak values and peak values relative to basal level will be calculated.
Time frame: Immediately after procedure.
Delayed responses will be examined by inspecting curves and by comparing area under the curve at the different blood sampling time points during the test.
Time frame: Immediately after procedure.
Delayed responses will be examined by inspecting curves and by comparing area under the curve at the different blood sampling time points during the test.
Time frame: Immediately after procedure.
Delayed responses will be examined by inspecting curves and by comparing area under the curve at the different blood sampling time points during the test.
Time frame: Immediately after procedure.
Delayed responses will be examined by inspecting curves and by comparing area under the curve at the different blood sampling time points during the test.
Time frame: Immediately after procedure.
Delayed responses will be examined by inspecting curves and by comparing area under the curve at the different blood sampling time points during the test.
Aalborg University Hospital
Other
Age-related Differences in the Response to a Combined Pituitary Stimulation Test With TRH, LHRH and ACTH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04042753
Brain Diseases, Brain Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT03636568
Brain Diseases, Brain Neoplasms
St Louis, Missouri, United States
View Trial DetailsNCT04119206
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT01705821
Brain Diseases, Central Nervous System Diseases
Nashville, Tennessee, United States
View Trial Details